Pering, Christiane (Bayer 201501 CMO + Head Innovation of Medical Care division of Bayer HealthCare) |
Chief Medical Officer (CMO) |
Bayer (Group) |
Germany |
Perkin, Eleanor (Huntsworth 202109 at Medistrava Consulting) |
Public Relations Manager / Investor Relations Manager |
Inizio (Group) |
United Kingdom (GB) |
Perl, Thomas (Eyesight & Vision 201110 Managing Director Sales + Marketing) |
Managing Director |
Eyesight & Vision GmbH |
Germany |
Perlitz, Uwe (Deutsche Bank Research 200503) |
Analyst (Financial / Industry) |
Deutsche Bank (Group) |
Germany |
Perlmutter, Roger M. (Merck (US) 2013– EVP + President of Merck Research Labs before Amgen 2001–2012) |
President/Director/Head Business Group/Unit/Division |
Amgen (Group) |
United States (USA) |
Perpeet, Markus (SAW Instruments 2010– Managing Director + co-founder before Caesar Projektleiter S-sens biosensor) |
Managing Director |
NanoTemper (Group) |
Germany |
Perreault, Paul (CSL 202006 CEO + Managing Director) |
Chief Executive Officer (CEO) |
CSL (Group) |
Australia |
Perrier, Marine (Enterome 202103 Head of External Communications + IR before Citigate Dewe Rogerson) |
Public Relations Manager / Investor Relations Manager |
Enterome S.A. |
France |
Perron, Hervé (GeNeuro 201702 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
GeNeuro S.A. (Euronext Paris: GNRO) |
Switzerland |
Perronnet, Xavier (Ion Opticks 202410) |
Chief Executive Officer (CEO) |
Ion Opticks Pty Ltd. (IonOpticks) |
Australia |
Perry, Benjamin (DNDi 201909 Senior Discovery Manager + Research Scientist) |
n. a. |
DNDi (Drugs for Neglected Diseases initiative) |
Switzerland |
Perry, Matthew (BVF Partners 201308 Portfolio Manager at Biotechnology Value Fund) |
Investment Manager |
BVF Partners L.P. (Biotechnology Venture Fund) |
United States (USA) |
Persigehl, Peter (Eurofins 201405 Managing Director at Eurofins Genomics GmbH) |
Managing Director |
Eurofins (Group) |
Germany |
Persson, Magnus (Eir Ventures 202007– Founding Parter before General Partner at HealthCap) |
General Partner (venture partner) |
Eir Ventures (Group) |
Sweden |
Persson, Ted (EQT 202405 Partner at EQT Ventures) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
Luxembourg |
Pertile, Paolo (Cutech 201905 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Symrise (Group) |
Italy |
Peschen, Dieter (AgroProtec 2010– Managing Director + co-founder) |
Managing Director |
AgroProtect GmbH |
Germany |
Pesquin, Gustavo (Bayer 202303– CEO of AskBio before Amneal Pharma + Sanofi + Abbott + Pfizer + P&G+ BCG) |
Chief Executive Officer (CEO) |
Bayer (Group) |
United States (USA) |
Pessara, Ulrich (IcanoMab 202009 CBO before Staatz Business Development + Strategy) |
Chief Business Officer (CBO) |
IcanoMab GmbH |
Germany |
Pestano, Gary (Biodesix 201304 Head Product Development + Lab Operations) |
Research & Development Manager |
Biodesix Inc. |
United States (USA) |
Peter, Jochen F. (SensScreen 200909– CEO + founder) |
Managing Director |
SensScreen Technologies GmbH |
Germany |
Peter-Katalinic, Jasna (Univ Münster 1996– Professor before Univ Bonn before Texas A+M Univ before Univ Zürich) |
Professor |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
Péterfy, Ferenc (Diagnosticum (HU) 201708 President) |
President/Director/Head Business Group/Unit/Division |
Diagnosticum (HU) (Group) |
Hungary |
Peters, Andreas C. (GSK Stockmann 201704 Lawyer at Hamburg Office) |
Attorney / Lawyer |
|
|
Peters, Björn (CDR-Life 202204 CBO) |
Chief Business Officer (CBO) |
CDR-Life AG |
Switzerland |
Peters, Dirk (Assaymatic GmbH 201110 Managing Director) |
Managing Director |
Assaymatic GmbH |
Germany |
Peters, Katharina (High-Tech Gründerfonds 202212 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
Peters, Malte (MorphoSys 201703–202212 Chief Development Officer before Sandoz + Novartis + Micromet RETIRED 12/22) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Novartis (Group) |
Germany |
Peters, Ole (Bayer 201612 Digital Farming Technology Lead at Bayer CropScience) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
Peters, Sabine (Amodia Bioservice 2003) |
n. a. |
Amodia Bioservice GmbH |
Germany |
Peters, Sonja (Q-Bioanalytic 200607) |
n. a. |
Eurofins (Group) |
Germany |
Peters, Wilt (Molecular Sensing 201112– Managing Director of Molecular Sensing GmbH) |
Managing Director |
Molecular Sensing (Group) |
Germany |
Petersen, Kaj (Gerstel 201003 Marketing Manager) |
Sales Manager / Marketing Manager |
Gerstel (Group) |
Germany |
Petersen, Tilmann (High-Tech Gründerfonds 202404 Investment Manager before AMSilk + CytoSwitch + Nu Emotions) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
Peterson, Sandra E. (JnJ 201212– before Bayer 201010–201211 CEO of Bayer CropScience before Bayer HealthCare) |
Chief Executive Officer (CEO) |
Johnson & Johnson (JnJ) (Group) |
United States (USA) |
Petkov, Jordan (Lonza 201703– Global Head of Research + Technology at Lonza Consumer Care before KLK POleo + Unilever) |
Research & Development Manager |
Lonza (Group) |
Switzerland |
Petraß, Jörg (Mologen –201512 CFO LEFT 12/15) |
Chief Financial Officer (CFO) |
Mologen (Group) |
Germany |
Petri, Alfred (Evonik 201308 SVP Sales + Marketing of Health + Nutrition Business Unit) |
Sales Manager / Marketing Manager |
Evonik (Group) |
Germany |
Petrone, Raffaele (Therametrics 201310– CEO) |
Chief Executive Officer (CEO) |
Relief Therapeutics (Group) |
Switzerland |
Petrovic, Marija (Ten23 Health 202410) |
n. a. |
Ten23 Health AG |
Switzerland |
Petrovic, Shacey (Insulet 202007 CEO) |
Chief Executive Officer (CEO) |
Insulet Corporation |
United States (USA) |
Petrovics, Tamás (Xund Solutions 202209 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Xund Solutions GmbH |
Austria |
Pettigrew, Michel (Ferring Pharmaceuticals 200105– COO before BMS) |
Chief Operating Officer (COO) |
Ferring (Paulsen Foundation) (Group) |
United Kingdom (GB) |
Petzholdt-Gühne, Grit (Analytik Jena 201306– Head of Huma Resources before Schott AG Jena + Daimler + Coca Cola) |
Human Resources Manager |
Endress+Hauser (Group) |
Germany |
Peukert, Uwe (ActeaVentures 201403– Managing Partner before Roche + Lilly + Onyx + NewVac) |
Managing Director |
ActeaVentures GmbH |
Germany |
Peyer, James (Apollo Ventures 201902 Managing Partner) |
Managing Partner |
Apollo Health Ventures (Group) |
Germany |
Peyro-Saint-Paul, Helene (PathoQuest 201610 CMO) |
Chief Medical Officer (CMO) |
PathoQuest SAS |
France |
Peyroles, Alexis (OSE Pharma 201504 CFO) |
Chief Financial Officer (CFO) |
OSE Immunotherapeutics (Group) |
France |
Pfaadt, Thomas (c-LEcta 201808– CFO) |
Chief Financial Officer (CFO) |
Kerry Group (Group) |
Germany |
Pfahlert, Volker (LipoFIT GmbH 201001– Managing Director COO before Roche Diagnostics + Dräger Medical) |
Managing Director |
Roche (Group) |
United States (USA) |
Pfannes, Othmar (Genedata 200406 CEO + Founder) |
Chief Executive Officer (CEO) |
Danaher (Group) |
Switzerland |
Pfannkuche, Jens (Gilupi 201612 Managing Director) |
Managing Director |
Viroad (Group) |
Germany |
Pfeffer, Patrick (Aescuvest 202408 CEO) |
Chief Executive Officer (CEO) |
Aescuvest GmbH |
Germany |
Pfeiffer, Christian (da-cons GmbH 201504 Managing Director + CO-Founder) |
Managing Director |
da-cons GmbH |
Germany |
Pfeil, Esther (Merlin Diagnostika GmbH 201709 Managing Director) |
Managing Director |
Bruker (Group) |
Germany |
Pfirmann, Ralf (Klocke 201308 CEO of IDT Bioligika GmbH) |
Managing Director |
Klocke (Group) |
Germany |
Pfirrmann, Jörg (Sartorius 2009–201702 CFO RESIGNED 2/17) |
Chief Financial Officer (CFO) |
Sartorius (Group) |
Germany |
Pfister, Bernd (Invision 200610 CEO) |
Chief Executive Officer (CEO) |
Invision (Group) |
Switzerland |
Pfister, Franz (Deepc 202303 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Deepc GmbH |
Germany |
Pfister, Martin (High-Tech Gründerfonds 201101 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
Pfleiderer, Wolfgang (Chemogenix 2000) |
n. a. |
Roche (Group) |
Germany |
Pflüger, Konstanze (Humboldt Univ Berlin 202406 Head of Communications + Press Officer at BIH) |
Public Relations Manager / Investor Relations Manager |
Humboldt University Berlin |
Germany |
Pfuhl, Andreas (Luxendo 201701 Managing Director) |
Managing Director |
Bruker (Group) |
Germany |
Pfundner, Hagen (Roche 202405– CEO of Roche Deutschland Holding before CEO of Roche Pharma AG) |
Chief Executive Officer (CEO) |
Roche (Group) |
Germany |
Pheiffer, Joachim (Biopract GmbH 201704 Managing Director) |
Managing Director |
Biopract GmbH [since 8/12] |
Germany |
Phelan, Maurice (Sartorius 202406 President of Sartorius North America) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
Phelps, Robert (Lophius Biosciences 201311– Director Business Operations before SuppreMol + PARI Pharma) |
Business Development Manager / Strategy Manager |
Mikrogen GmbH |
Germany |
Phi, Janette (ThinkCyte 202212 CBO formerly IntelliCyt 201506 Chief Business Officer) |
Chief Business Officer (CBO) |
ThinkCyte K.K. |
Japan |
Philipp, Christoph (CellTec Systems 202305 Managing Director) |
Managing Director |
CellTec Systems GmbH |
Germany |
Philippe, Olivier (GeneBio 201005 Sales + Marketing Director) |
Sales Manager / Marketing Manager |
GeneBio (Group) |
Switzerland |
Philippsen, Peter |
n. a. |
University of Basel |
Switzerland |
Philips, Craig W. (Cell Therapeutics 200808– before Bayer Healthcare Oncology) |
n. a. |
Cell Therapeutics (Group) |
United States (USA) |
Philips, Julien (Genedata 201006 Product Manager) |
Product Manager (personnel) |
Danaher (Group) |
Switzerland |
Philips, Mario (Polyplus-transfection, 202011– CEO before PolyNeuros + ArchiMed + Pall Biotech + ATMI Life Sciences) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
France |
Phillips, Andrew (Andy) (Cormorant Asset Management 202101 before C4 Therapeutics 201901 CEO) |
Managing Director |
Cormorant Asset Management LP (LLC?) |
United States (USA) |
Phillips, Barcley A. (Buck) (G1 Therapeutics 201711– CFO + SVP CorpDev before Novavax + Micromet + Vector Fund Mgt) |
Chief Financial Officer (CFO) |
Amgen (Group) |
United States (USA) |
Phillips, Gary (Pharmaxis 201505 CEO) |
Chief Executive Officer (CEO) |
Pharmaxis Ltd. (ASX: PXS) |
Australia |
Phillips, Julia (FTI Consulting 201110) |
Public Relations Manager / Investor Relations Manager |
FTI Consulting (Group) |
United Kingdom (GB) |
Piazzalunga, Fabio (Menarini 201809 General Manager at Menarini Diagnostics) |
General Manager (management) |
Menarini (Group) |
Italy |
Picard, Emmanuel (Chemie Brunschwig 201509 Marketing + Sales Manager) |
Sales Manager / Marketing Manager |
Chemie Brunschwig AG |
Switzerland |
Picaud, Géraldine (SGS 202403– CEO joined 202312 as CFO before Holcim + Essilor + Safic Alcan + ED&F Man Group) |
Chief Executive Officer (CEO) |
SGS (Group) |
Switzerland |
Pichler, Garwin (PreOmics GmbH 201601– Managing Director + Co-Founder) |
Managing Director |
Bruker (Group) |
Germany |
Pichler, Peter (Brechbühler 201709 General Manager) |
General Manager (management) |
Brechbühler AG |
Switzerland |
Pichler, Ricarda (Sony 201308 Head of Marketing BioSciences at Sony DADC) |
Sales Manager / Marketing Manager |
Stratec (Group) |
Austria |
Pichota, Aradius (Novartis 202406– CEO of MorphoSys before Navigate BioPharma Services Inc) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Germany |
Pick, André (Cascat GmbH 201504 Managing Director) |
Managing Director |
Cascat GmbH |
Germany |
Pickering, Catherine (iOnctura 201706– CEO + Co-Founder before Merck Head Global Oncology Licensing + BusDev) |
Chief Executive Officer (CEO) |
iOnctura (Group) |
Switzerland |
Pickering, Paul J. (Maverix Biomics 201306– COO before Life Technologies) |
Chief Operating Officer (COO) |
Maverix Biomics Inc. |
United States (USA) |
Pickuth, Andreas (InProcess 201001– Managing Director) |
Managing Director |
InProcess Instruments Gesellschaft für Prozessanalytik mbH (IPI) |
Germany |
Picone, Stephen (ArcherDx 201501– Exec Director Corp Development before Enzymatics Co-founder) |
Business Development Manager / Strategy Manager |
ArcherDX Inc. |
United States (USA) |
Picot, Arnold (Univ München before TU München before Univ Hannover Professor) |
Professor |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
Picotti, Paola (ETH Zürich 202008 Assoc Professor in Molecular Systems Biology + Group Leader) |
Assistant Professor / Associate Professor |
ETH Zürich (ETHZ) |
Switzerland |
Pieber, Thomas (CBmed 202402 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
CBmed GmbH Center for Biomarker Research in Medicine |
Austria |
Piëch, Valentin (BioMedPartners 202205 Partner) |
Partner (venture partner) |
BioMedPartners (Group) |
Switzerland |
Piecuch, Miriam (Public Performance 202002) |
Public Relations Manager / Investor Relations Manager |
Public Performance – Miriam Piecuch, Kommunikationsberatung & PR |
Germany |
Pieken, Wolfgang (Inveni Capital 200805 Inveni Capital GmbH Munich before MWG Biotech CEO) |
Partner (venture partner) |
Inveni Capital (Group) |
Germany |
Piening, Barthold (Qiagen 201812– SVP Head of Global Operations before Stada + Altana Pharma + Nycomed + Takeda) |
Chief Operating Officer (COO) |
Qiagen (Group) |
Netherlands |
Piepenbrock, Christian (Epigenomics 200410–200804 COO left 4/08) |
Chief Operating Officer (COO) |
Epigenomics (Group) |
Germany |
Piepenstock (Weiss), Oliver (Noah Labs 202409 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Noah Labs GmbH (until 7/24 UG) |
Germany |
Pieper, Dietmar (GBF 200503) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |